HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shin Hwang Selected Research

hepatitis B hyperimmune globulin

2/2020Hepatitis B Prophylaxis after Liver Transplantation in Korea: Analysis of the KOTRY Database.
10/2019Determination of Hepatitis B Immunoglobulin Infusion Interval Using Pharmacokinetic Half-life Simulation for Posttransplant Hepatitis B Prophylaxis.
5/2019Assessment of patient safety and the efficiency of facility utilization following simplified ultra-rapid intravenous infusion of hepatitis B immunoglobulin in a high-volume liver transplantation center.
4/2011Posttransplantation prophylaxis with primary high-dose hepatitis B immunoglobulin monotherapy and complementary preemptive antiviral add-on.
6/2008Prevention of hepatitis B recurrence after living donor liver transplantation: primary high-dose hepatitis B immunoglobulin monotherapy and rescue antiviral therapy.
6/2006Five-year follow-up of a hepatitis B virus-positive recipient of hepatitis B surface antigen-positive living donor liver graft.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shin Hwang Research Topics

Disease

73Hepatocellular Carcinoma (Hepatoma)
03/2022 - 11/2002
72Neoplasms (Cancer)
07/2022 - 10/2005
21Pathologic Constriction (Stenosis)
01/2022 - 01/2003
17Hepatitis B
06/2022 - 02/2003
16Neoplasm Metastasis (Metastasis)
06/2021 - 03/2007
15Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 06/2010
14Liver Failure
05/2021 - 11/2002
12Cholangiocarcinoma
07/2022 - 06/2007
12End Stage Liver Disease
01/2022 - 05/2003
11Thrombosis (Thrombus)
12/2021 - 02/2003
11Hemorrhage
11/2021 - 06/2004
9Fibrosis (Cirrhosis)
01/2022 - 06/2004
8Klatskin Tumor
08/2021 - 07/2009
8Liver Diseases (Liver Disease)
09/2020 - 01/2009
8Infections
03/2018 - 02/2003
7Acute Liver Failure (Fulminant Hepatic Failure)
01/2018 - 11/2008
6Bile Duct Neoplasms (Bile Duct Cancer)
11/2021 - 03/2007
6Atrophy
11/2015 - 06/2007
5Biliary Atresia
01/2022 - 12/2020
4Carcinoma (Carcinomatosis)
01/2022 - 09/2010
4Margins of Excision
08/2021 - 06/2007
4Gallbladder Neoplasms (Gallbladder Cancer)
02/2021 - 10/2014
4Wounds and Injuries (Trauma)
09/2020 - 06/2007
4Hepatitis C
12/2017 - 09/2003
3Sepsis (Septicemia)
10/2022 - 11/2021
3Hepatorenal Syndrome
10/2022 - 06/2006
3Diabetes Mellitus
10/2022 - 08/2020
3progressive familial intrahepatic 1 Cholestasis
03/2022 - 09/2020
3Disease Progression
05/2021 - 09/2002
3Acute-On-Chronic Liver Failure
01/2021 - 12/2012
3Adenocarcinoma
01/2021 - 05/2019
3Cholangitis
08/2020 - 07/2010
3Reperfusion Injury
01/2020 - 12/2016
3Hypoxia (Hypoxemia)
12/2019 - 06/2012
3Hyperemia
10/2016 - 06/2004
2Gastroparesis
07/2022 - 02/2016
2Thrombocytopenia (Thrombopenia)
12/2021 - 01/2014
2Pneumonia (Pneumonitis)
11/2021 - 09/2021
2Heterotaxy Syndrome
05/2021 - 12/2020
2Epithelioid Hemangioendothelioma
03/2021 - 12/2016
2Alcoholic Liver Diseases (Alcoholic Liver Disease)
08/2020 - 02/2013
2Biliary Tract Neoplasms (Biliary Tract Cancer)
04/2020 - 10/2019
2Hepatoblastoma
02/2020 - 05/2019
2Budd-Chiari Syndrome (Budd Chiari Syndrome)
01/2019 - 05/2011
2Cholelithiasis
11/2018 - 12/2012
2Lymphatic Metastasis
04/2018 - 08/2017
2Inflammation (Inflammations)
01/2018 - 06/2004

Drug/Important Bio-Agent (IBA)

10Sorafenib (BAY 43-9006)FDA Link
06/2021 - 08/2010
8Biomarkers (Surrogate Marker)IBA
04/2020 - 10/2011
7Immunoglobulins (Immunoglobulin)IBA
02/2020 - 03/2005
6perfluoro- 2,2,2',2'- tetramethyl- 4,4'- bis(1,3- dioxolane)IBA
01/2022 - 06/2007
6hepatitis B hyperimmune globulinIBA
02/2020 - 06/2006
5Fetal Proteins (Fetoprotein)IBA
11/2021 - 01/2018
5Antiviral Agents (Antivirals)IBA
09/2021 - 03/2005
5alpha-Fetoproteins (alpha-Fetoprotein)IBA
11/2020 - 10/2005
4Proteins (Proteins, Gene)FDA Link
01/2022 - 04/2013
4Pharmaceutical PreparationsIBA
12/2021 - 08/2010
4Tumor Biomarkers (Tumor Markers)IBA
01/2019 - 10/2016
4Therapeutic UsesIBA
08/2018 - 03/2005
3Lamivudine (Epivir)FDA Link
03/2021 - 03/2005
3AntigensIBA
12/2018 - 08/2017
3Metformin (Glucophage)FDA LinkGeneric
11/2018 - 01/2018
3Hepatitis B Surface Antigens (HBsAg)FDA Link
03/2018 - 06/2006
2CreatinineIBA
10/2022 - 07/2021
2MucinsIBA
07/2022 - 08/2016
2Tenofovir (Viread)FDA Link
06/2022 - 02/2016
2Glucose (Dextrose)FDA LinkGeneric
01/2022 - 06/2020
2Fibrin Tissue Adhesive (Fibrin Sealant)IBA
11/2021 - 11/2016
2BilirubinIBA
09/2021 - 12/2007
2Indocyanine Green (Cardio-Green)FDA LinkGeneric
11/2020 - 01/2005
2BismuthIBA
08/2020 - 02/2015
2EverolimusFDA Link
12/2019 - 05/2018
2SynaptophysinIBA
10/2019 - 04/2008
2ChromograninsIBA
10/2019 - 04/2008
2Prothrombin (Factor II)IBA
12/2018 - 01/2018
2Alkaline PhosphataseIBA
11/2018 - 11/2013
2Cisplatin (Platino)FDA LinkGeneric
11/2018 - 01/2018
2GemcitabineFDA Link
11/2018 - 01/2018
2Immunosuppressive Agents (Immunosuppressants)IBA
02/2018 - 06/2016

Therapy/Procedure

131Liver Transplantation
10/2022 - 09/2002
39Hepatectomy
11/2021 - 06/2004
21Therapeutics
09/2021 - 11/2002
18Transplantation
12/2021 - 05/2010
14Pancreaticoduodenectomy
11/2021 - 03/2007
10Stents
05/2021 - 02/2003
6Drug Therapy (Chemotherapy)
05/2020 - 09/2010
6Laparoscopic Cholecystectomy
11/2015 - 06/2007
5Kidney Transplantation
12/2021 - 08/2020
4Lymph Node Excision (Lymph Node Dissection)
07/2022 - 03/2009
4Radiotherapy
08/2018 - 05/2013
3Ligation
01/2022 - 07/2007
3Operative Surgical Procedures
11/2021 - 01/2008
3Cholecystectomy
02/2021 - 03/2016
3Immunotherapy
01/2021 - 03/2019
3Length of Stay
02/2016 - 11/2009
2Contraindications
01/2022 - 05/2020
2Metastasectomy
05/2021 - 05/2020
2Adjuvant Chemotherapy
02/2021 - 08/2017
2Renal Replacement Therapy (Therapies, Renal Replacement)
09/2020 - 02/2020
2Splenectomy
05/2019 - 11/2009